MetLife Investment Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1529735
Whippany, NJ
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,989,202
-$480,416 QoQ
Shares Held
53,053
+0.7% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in NBIX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,989,202 | 53,053 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,469,618 | 52,666 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,701,387 | 54,861 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,167,723 | 57,027 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,603,594 | 59,707 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,386,833 | 61,442 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,533,780 | 56,707 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,930,067 | 57,602 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,082,663 | 58,604 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $7,819,692 | 59,348 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,746,400 | 59,968 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $5,891,864 | 62,480 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,380,099 | 63,032 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,676,408 | 64,270 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $6,939,230 | 65,335 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $6,435,434 | 66,018 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $6,141,468 | 65,509 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $3,915,605 | 45,974 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $4,360,931 | 45,469 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $4,597,591 | 47,242 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $4,719,153 | 48,526 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||